2-Aminobenzothiazoles Inhibit Virulence Gene Expression and Block Polymyxin Resistance in Salmonella enterica.
Michaela K ThielenCody K VaneerdManibarsha GoswamiErin E CarlsonJohn F MayPublished in: Chembiochem : a European journal of chemical biology (2020)
One promising strategy to combat antibiotic-resistant bacteria is to develop compounds that block bacterial defenses against antibacterial conditions produced by the innate immune system. Salmonella enterica, which causes food-borne gastroenteritis and typhoid fever, requires histidine kinases (HKs) to resist innate immune defenses such as cationic antimicrobial peptides (CAMPs). Herein, we report that 2-aminobenzothiazoles block histidine kinase-dependent phenotypes in Salmonella enterica serotype Typhimurium. We found that 2-aminobenzothiazoles inhibited growth under low Mg2+ , a stressful condition that requires histidine kinase-mediated responses, and decreased expression of the virulence genes pagC and pagK. Furthermore, we discovered that 2-aminobenzothiazoles weaken Salmonella's resistance to polymyxin B and polymyxin E, which are last-line antibiotics and models for host defense CAMPs. These findings raise the possibilities that 2-aminobenzothiazoles can block HK-mediated bacterial defenses and can be used in combination with polymyxins to treat infections caused by Salmonella.
Keyphrases
- escherichia coli
- innate immune
- gene expression
- pseudomonas aeruginosa
- listeria monocytogenes
- staphylococcus aureus
- immune response
- gram negative
- biofilm formation
- poor prognosis
- antimicrobial resistance
- dna methylation
- protein kinase
- genome wide
- klebsiella pneumoniae
- dengue virus
- long non coding rna
- risk assessment
- cystic fibrosis
- multidrug resistant
- anti inflammatory
- silver nanoparticles
- disease virus